The Use of Humor With Young Adults in Psychiatric Care

Status Completed

Clinical Trial Summary

Clinical study in psychiatry in young adult patients between 18 and 25 years old. The aim of the study is to evaluate the therapeutic impact of the clinical use of humor through 6 group sessions (group of 5 to 10 patients), at the rate of one hour session per week for 6 weeks. The investigators will form 2 groups of 5 to 10 patients matched in terms of gender, education level and score on a scale measuring their sense of humor. The participants will be asked to complete a series of tests measuring their ability to use humor, psychiatric symptoms and well-being. Group 1 (test group) will participate in the humor-based sessions, while Group 2 (control group) will receive regular treatment for 6 weeks (waiting list: patients in Group 2 will attend humor-based sessions once Group 1 has completed their 6 weeks). At the end of the 6-week sessions, both groups will receive the same series of pre-session tests to see whether or not there has been improvement in their overall functioning, psychiatric symptomatology and appreciation/use of humor. At the end of the 2x 6-week sessions, group 2 will again receive this series of pre-session tests to see whether or not their overall functioning, psychiatric symptomatology and appreciation/use of humour has improved. Objective(s)/Aim: To evaluate the resilience of young adult psychiatric patients and their ability to cope with stress through the use of humor in a set of 6 modules on the use of humor. To evaluate the symptoms. Outcome/Endpoints : Using scales, measure this evolution.

Clinical Trial Description

Project design and procedures : The investigators will form 2 groups of 5 to 10 patients matched on their score on the sense of humor scale, their gender and their level of education. The participants will be asked to complete a series of tests measuring their ability to use humor, clinical variables and general functioning. Group 1 - experimental - will participate in a "humor group" with a one-hour group session per week for 6 weeks. Group 2 - the control group - will follow a usual treatment regimen for 6 weeks. At the end of the "Humor Group" of group 1, the 2 groups of patients will undergo a second series of tests identical to those of the pregroup. The paired patients should be randomly assigned. The control group will do the "Humor Group" after 6 weeks. ;

Study Design

Related Conditions & MeSH terms

Mental Disorders
Problem Behavior
Psychiatric Disorder
Treatment Adherence and Compliance

Clinical Trial Details

NCT number	NCT04778163
Study type	Interventional
Source	University Hospital, Geneva
Contact
Status	Completed
Phase	N/A
Start date	September 19, 2019
Completion date	October 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03409991` - Testing the Efficacy of Opening Doors: A Career Guidance Intervention for Individuals With Psychiatric Disabilities	N/A
Not yet recruiting	`NCT05316948` - Mental Health and Sexuality in Adolescents and Young Adults
Not yet recruiting	`NCT06304363` - Braining - Evaluation of Acute Effects of Physical Exercise	N/A
Recruiting	`NCT04096625` - Enhancement of a Psychotherapeutic Intervention Through Transcranial Direct Current Stimulation (tDCS)	N/A
Not yet recruiting	`NCT05930353` - Psychometric Validation of a French-language Version of the PERMA-Profiler: Tools for Assessing Multidimensional Subjective Well-being
Terminated	`NCT06012981` - Psychological Treatment in Psychiatric Inpatient Care	N/A
Completed	`NCT04099173` - A Brief Mindfulness-Based Intervention for Suicidal Ideation	N/A
Completed	`NCT01866956` - Computerized Screening for Comorbidity in Adolescents With Substance or Psychiatric Disorders
Recruiting	`NCT04249960` - Sustain and Reinforce the Transition From Child to Adult Mental Health Care in Switzerland : A Monocentric Nested Cohort Randomized Controlled Trial: The SORT Study.	N/A
Recruiting	`NCT05962424` - HNC: Human Neural Circuits Electrophysiology During Cognition	Phase 1
Recruiting	`NCT06092866` - Digital Versus Telephone Symptom Assessment and Triage in Primary Care	N/A
Recruiting	`NCT03678194` - Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application	N/A
Completed	`NCT03748355` - Using Pharmacogenetics to Identify Patients With Polypharmacy at Risk of Medication Adverse Effects	N/A
Completed	`NCT05473962` - Mid-Term Follow-up Assessment After Exposure to Natural Disaster
Recruiting	`NCT05577585` - Ketamine and Stress in OCD	N/A
Completed	`NCT05124158` - COVID-19 Severity and Psychiatric Morbidity
Recruiting	`NCT05560581` - Digital Self-efficacy Training to Bridge Waiting Times for Psychotherapy	N/A
Completed	`NCT04618250` - Improving Physical Health in Patients With Psychiatric Disorders in General Practice (SOFIA)	N/A
Not yet recruiting	`NCT06014164` - Qualitative Study About Psychedelics Using in Psychiatric Disorders
Active, not recruiting	`NCT05219357` - Ayurveda Based Intervention for Patients in Acute Psychiatric Crisis Situations	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.